Researchers investigated the potential implications of single-nucleotide variations in gut-residing bacterial species (microbiome) on human health.
Scientists develop Australia’s first-of-its-kind next-gen mpox diagnostic tool
In a collaborative study published in The Lancet Microbe, the team of scientists, led by the Peter Doherty Institute for Infection and Immunity (Doherty Institute)